menu
    • menu

    Company profile for MindBio Therapeutics

    NEW Drugs in Dev: 1
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    Evonik Health Care is the innovation hub for leading life science companies

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    MindBio Therapeutics is a clinical stage drug development company that is pioneering psychedelic microdosing. With its first candidate drug LSD currently in Phase 1 clinical trials microdosing LSD in 80 healthy participants. In a world first clinical trial of its kind, participants are prescribed the microdoses of LSD to take home with them after receiving a battery of psychological and biometric baseline tests in the laborato...
    MindBio Therapeutics is a clinical stage drug development company that is pioneering psychedelic microdosing. With its first candidate drug LSD currently in Phase 1 clinical trials microdosing LSD in 80 healthy participants. In a world first clinical trial of its kind, participants are prescribed the microdoses of LSD to take home with them after receiving a battery of psychological and biometric baseline tests in the laboratory. Phase 2 clinical trials microdosing LSD have just been approved in late stage cancer patients experiencing existential distress, anxiety and depression.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    MindBio TherapeuticsAustralia Flag
    Country
    Country
    Australia
    Address
    Address
    Level 4, 91-97 William Street Melbourne, 3000
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.mindbiotherapeutics.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/mindbio-therapeutics
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    euroPLX 90 Lisbon

    Not Confirmed

    envelop Contact Supplier

    euroPLX 90 Lisbon

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    MindBio Reports Sustained Response In Microdosing Depression Trials
    MindBio Reports Sustained Response In Microdosing Depression Trials

    19 Aug 2024

    // ACCESSWIRE

    https://www.accesswire.com/903323/mindbio-announces-sustained-antidepressant-response-3-months-post-treatment-in-microdosing-depression-clinical-trials

    ACCESSWIRE
    19 Aug 2024
    Share Share
    MindBio Therapeutics Appoints Haywood Securities As Advisor
    MindBio Therapeutics Appoints Haywood Securities As Advisor

    01 Aug 2024

    // ACCESSWIRE

    https://www.accesswire.com/viewarticle.aspx?id=895264&lang=en

    ACCESSWIRE
    01 Aug 2024
    Share Share
    Mindbio Therapeutics CEO Issues Letter To Shareholders
    Mindbio Therapeutics CEO Issues Letter To Shareholders

    08 Jul 2024

    // ACCESSWIRE

    https://www.accesswire.com/viewarticle.aspx?id=886099&lang=en

    ACCESSWIRE
    08 Jul 2024
    Share Share
    MindBio Reports Sustained Antidepressant Effect Of MB22001 In Depression Trial
    MindBio Reports Sustained Antidepressant Effect Of MB22001 In Depression Trial

    20 Jun 2024

    // ACCESSWIRE

    https://www.accesswire.com/viewarticle.aspx?id=879528&lang=en

    ACCESSWIRE
    20 Jun 2024
    Share Share
    MindBio Therapeutics Reports Phase 2A Depression Trial Results
    MindBio Therapeutics Reports Phase 2A Depression Trial Results

    12 Jun 2024

    // ACCESSWIRE

    https://www.accesswire.com/viewarticle.aspx?id=876510&lang=en

    ACCESSWIRE
    12 Jun 2024
    Share Share
    Enveric Biosciences to out-license psilocin prodrug to MindBio
    Enveric Biosciences to out-license psilocin prodrug to MindBio

    15 May 2024

    // PHARMACEUTICAL TECHNOLOGY

    https://www.pharmaceutical-technology.com/news/enveric-psilocin-prodrug-mindbio/

    PHARMACEUTICAL TECHNOLOGY
    15 May 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search